1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
0000-0002-4697-6602
Daly, N.L.
Dekan, Z.
Jin, A.H.
Alewood, P.F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
GE
Angew. Chem. Int. Ed. Engl.
ACIEAY
0179
1521-3773
56
14973
14976
10.1002/anie.201708927
28984021
Conotoxin phi-MiXXVIIA from the Superfamily G2 Employs a Novel Cysteine Framework that Mimics Granulin and Displays Anti-Apoptotic Activity.
2017
0000-0001-8891-1463
0000-0002-6841-4176
0000-0001-6937-0112
0000-0002-2945-1484
10.2210/pdb6ppc/pdb
pdb_00006ppc
3422.695
Conopeptide phi-MiXXVIIA
1
syn
polymer
Conopeptide Mi045
no
no
EDCGSDCMPCGGECCCEPNSCIDGTCHHESSPN
EDCGSDCMPCGGECCCEPNSCIDGTCHHESSPN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
pdbx_audit_support
pdbx_nmr_spectrometer
database_2
pdbx_database_status
repository
Initial release
Author supporting evidence
Data collection
Database references
Other
1
0
2019-08-14
1
1
2020-01-01
1
2
2023-06-14
_pdbx_audit_support.funding_organization
_pdbx_nmr_spectrometer.model
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
Australia
Australian Research Council (ARC)
FT110100226
Solution structure of conotoxin MiXXVIIA
N
RCSB
Y
RCSB
2019-07-06
REL
REL
REL
REL
69564
Soldier cone
Conus miles
sample
1
33
target function
50
15
isotropic
1
2D DQF-COSY
isotropic
1
2D 1H-1H TOCSY
isotropic
1
2D 1H-15N HSQC
isotropic
1
2D 1H-13C HSQC
isotropic
1
2D 1H-1H NOESY
isotropic
1
2D 1H-1H TOCSY
isotropic
1
2D 1H-1H NOESY
1
mM
natural abundance
1
mM
natural abundance
0% salt
Not defined
1
5
pH
ambient
290
K
simulated annealing
1
lowest energy
1 mM phi-MiXXVIIA, 90% H2O/10% D2O
1
90% H2O/10% D2O
solution
1 mM phi-MiXXVIIA, 100% D2O
2
100% D2O
solution
Bruker Biospin
collection
TopSpin
CCPN
data analysis
CcpNmr Analysis
Guntert, Mumenthaler and Wuthrich
refinement
CYANA
Guntert, Mumenthaler and Wuthrich
structure calculation
CYANA
600
Bruker
AVANCE
GLU
1
n
1
GLU
1
A
ASP
2
n
2
ASP
2
A
CYS
3
n
3
CYS
3
A
GLY
4
n
4
GLY
4
A
SER
5
n
5
SER
5
A
ASP
6
n
6
ASP
6
A
CYS
7
n
7
CYS
7
A
MET
8
n
8
MET
8
A
PRO
9
n
9
PRO
9
A
CYS
10
n
10
CYS
10
A
GLY
11
n
11
GLY
11
A
GLY
12
n
12
GLY
12
A
GLU
13
n
13
GLU
13
A
CYS
14
n
14
CYS
14
A
CYS
15
n
15
CYS
15
A
CYS
16
n
16
CYS
16
A
GLU
17
n
17
GLU
17
A
PRO
18
n
18
PRO
18
A
ASN
19
n
19
ASN
19
A
SER
20
n
20
SER
20
A
CYS
21
n
21
CYS
21
A
ILE
22
n
22
ILE
22
A
ASP
23
n
23
ASP
23
A
GLY
24
n
24
GLY
24
A
THR
25
n
25
THR
25
A
CYS
26
n
26
CYS
26
A
HIS
27
n
27
HIS
27
A
HIS
28
n
28
HIS
28
A
GLU
29
n
29
GLU
29
A
SER
30
n
30
SER
30
A
SER
31
n
31
SER
31
A
PRO
32
n
32
PRO
32
A
ASN
33
n
33
ASN
33
A
author_defined_assembly
1
monomeric
none
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
MET
8
A
N
MET
8
A
O
CYS
15
A
O
CYS
15
A
N
SER
20
A
N
SER
20
A
O
HIS
27
A
O
HIS
27
1
A
CYS
3
-96.99
-67.72
1
A
SER
5
-62.11
95.21
1
A
GLU
13
-120.44
-169.72
1
A
ASN
19
-52.81
173.35
2
A
SER
5
-62.02
95.23
2
A
GLU
13
-120.79
-169.76
2
A
ASN
19
-52.61
172.92
3
A
CYS
3
-100.12
-64.47
3
A
SER
5
-62.34
94.90
3
A
GLU
13
-126.65
-169.88
3
A
ASN
19
-52.27
172.23
4
A
SER
5
-62.33
94.99
4
A
GLU
13
-121.27
-169.76
4
A
ASN
19
-52.73
173.26
5
A
CYS
3
-91.38
-63.90
5
A
SER
5
-62.21
95.25
5
A
GLU
13
-120.36
-169.71
5
A
ASN
19
-53.00
173.70
6
A
SER
5
-62.02
95.11
6
A
GLU
13
-119.82
-169.75
6
A
ASN
19
-52.81
173.54
6
A
PRO
32
-69.78
98.67
7
A
SER
5
-62.15
95.02
7
A
GLU
13
-118.79
-169.59
7
A
ASN
19
-52.78
173.40
7
A
SER
30
-101.03
-74.32
8
A
SER
5
-62.24
95.05
8
A
GLU
13
-124.21
-169.92
8
A
ASN
19
-52.21
172.21
8
A
PRO
32
-69.77
86.44
9
A
SER
5
-62.09
95.26
9
A
GLU
13
-121.05
-169.56
9
A
ASN
19
-52.41
172.63
10
A
CYS
3
-103.27
-66.48
10
A
SER
5
-62.37
94.95
10
A
GLU
13
-127.97
-169.87
10
A
ASN
19
-52.18
172.16
11
A
CYS
3
-97.36
-64.14
11
A
SER
5
-62.37
94.95
11
A
ASN
19
-52.13
172.17
11
A
SER
31
-151.58
70.17
12
A
SER
5
-62.43
94.68
12
A
ASN
19
-52.17
172.20
12
A
SER
31
54.07
73.11
13
A
CYS
3
-100.33
-64.13
13
A
SER
5
-62.31
95.05
13
A
ASN
19
-52.21
172.46
13
A
SER
30
-115.50
51.89
14
A
SER
5
-62.45
94.64
14
A
GLU
13
-118.59
-169.57
14
A
ASN
19
-52.47
172.22
15
A
CYS
3
-104.49
-68.07
15
A
SER
5
-61.88
94.95
15
A
GLU
13
-117.78
-169.62
15
A
ASN
19
-52.25
172.00
15
A
SER
31
63.04
160.60
N
Solution structure of conotoxin MiXXVIIA
1
N
N
disulf
1.999
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
14
A
SG
CYS
14
1_555
disulf
2.103
A
CYS
7
A
SG
CYS
7
1_555
A
CYS
16
A
SG
CYS
16
1_555
disulf
2.023
A
CYS
10
A
SG
CYS
10
1_555
A
CYS
21
A
SG
CYS
21
1_555
disulf
1.932
A
CYS
15
A
SG
CYS
15
1_555
A
CYS
26
A
SG
CYS
26
1_555
TOXIN
TOXIN
A
GLU
17
A
GLU
17
1
A
PRO
18
A
PRO
18
-0.02
A
GLU
17
A
GLU
17
2
A
PRO
18
A
PRO
18
0.02
A
GLU
17
A
GLU
17
3
A
PRO
18
A
PRO
18
-0.01
A
GLU
17
A
GLU
17
4
A
PRO
18
A
PRO
18
0.01
A
GLU
17
A
GLU
17
5
A
PRO
18
A
PRO
18
-0.04
A
GLU
17
A
GLU
17
6
A
PRO
18
A
PRO
18
0.04
A
GLU
17
A
GLU
17
7
A
PRO
18
A
PRO
18
0.00
A
GLU
17
A
GLU
17
8
A
PRO
18
A
PRO
18
0.08
A
GLU
17
A
GLU
17
9
A
PRO
18
A
PRO
18
0.08
A
GLU
17
A
GLU
17
10
A
PRO
18
A
PRO
18
0.04
A
GLU
17
A
GLU
17
11
A
PRO
18
A
PRO
18
0.06
A
GLU
17
A
GLU
17
12
A
PRO
18
A
PRO
18
0.01
A
GLU
17
A
GLU
17
13
A
PRO
18
A
PRO
18
-0.03
A
GLU
17
A
GLU
17
14
A
PRO
18
A
PRO
18
-0.04
A
GLU
17
A
GLU
17
15
A
PRO
18
A
PRO
18
0.03
CG2RA_CONMI
UNP
1
36
A0A0E3SVE7
EDCGSDCMPCGGECCCEPNSCIDGTCHHESSPN
36
68
6PPC
1
33
A0A0E3SVE7
A
1
1
33
2
2
anti-parallel
anti-parallel
A
MET
8
A
MET
8
A
PRO
9
A
PRO
9
A
CYS
14
A
CYS
14
A
CYS
15
A
CYS
15
A
SER
20
A
SER
20
A
ILE
22
A
ILE
22
A
THR
25
A
THR
25
A
HIS
27
A
HIS
27